Bruno A. Cardoso
Lisbon, Portugal
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Epigenetic alterations in Myeloid Malignancies.
Journal: Advances in experimental medicine and biology
Published: July 11, 2026
Epigenetic Targeting in Myeloid Malignancies.
Journal: Advances in experimental medicine and biology
Published: July 11, 2026
Immune-monitoring of myelodysplastic neoplasms: Recommendations from the i4MDS consortium.
Journal: HemaSphere
Published: January 31, 2024
CASZ1 upregulates PI3K-AKT-mTOR signaling and promotes T-cell acute lymphoblastic leukemia.
Journal: Haematologica
Published: February 10, 2023
The Bone Marrow Niche - The Tumor Microenvironment That Ensures Leukemia Progression.
Journal: Advances in experimental medicine and biology
Published: March 05, 2020
Vorinostat synergizes with antioxidant therapy to target myeloproliferative neoplasms.
Journal: Experimental hematology
Published: October 15, 2018
Acetylation drives hepatocyte nuclear factor 1β stability by blocking proteasome-mediated degradation.
Journal: Journal of cellular biochemistry
Published: August 01, 2018
From the outside, from within: Biological and therapeutic relevance of signal transduction in T-cell acute lymphoblastic leukemia.
Journal: Cellular signalling
Published: June 10, 2017
Optimal interleukin-7 receptor-mediated signaling, cell cycle progression and viability of T-cell acute lymphoblastic leukemia cells rely on casein kinase 2 activity.
Journal: Haematologica
Published: December 18, 2015
The Bone Marrow-Mediated Protection of Myeloproliferative Neoplastic Cells to Vorinostat and Ruxolitinib Relies on the Activation of JNK and PI3K Signalling Pathways.
Journal: PloS one
Published: September 04, 2015
Last Updated: 09/26/2026